Table 2 Baseline characteristics and radiation dose
Patient number | N = 44 |
|---|---|
Age (y) | 67 (64–74) |
Sex | |
Female | 13 (30%) |
Male | 31 (70%) |
Body height (cm) | 175 (169–178) |
Body weight (kg) | 79 (65–86) |
Body mass index (kg/m2) | 25.6 (23.1–28.0) |
Late arterial phase | |
CTDIvol (mGy) | 14 (12–16) |
DLP (mGy*cm) | 400 (300–450) |
Effective dose (mSv) | 6.1 (4.6 – 6.8) |
Portal venous phase | Abd / Abd + Pel / Th + Abd + Pel |
CTDIvol (mGy) | 14 (12–17) / 12 (12–12) / 16 (13–18) |
DLP (mGy*cm) | 370 (300–450) / 590 (540–630) / 1100 (890–1190) |
Effective dose (mSv) | 6.1 (4.4 – 6.8) / 8.7 (8.1 – 9.4) / 15.7 (13.3 – 17.8) |
Delayed phase | |
CTDIvol (mGy) | 14 (11–16) |
DLP (mGy*cm) | 400 (300–450) |
Effective dose (mSv) | 6.1 (4.5 – 6.8) |